Detalhe da pesquisa
1.
Phenotypic Characterization of SLex+ and CLA+ CD4+ T Cells.
STAR Protoc
; 1(3): 100154, 2020 12 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33377048
2.
Deep Immune Profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19.
medRxiv
; 2020 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32995826
3.
Avelumab, an IgG1 anti-PD-L1 Immune Checkpoint Inhibitor, Triggers NK Cell-Mediated Cytotoxicity and Cytokine Production Against Triple Negative Breast Cancer Cells.
Front Immunol
; 9: 2140, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30294328
4.
Changes in the TCRß Repertoire and Tumor Immune Signature From a Cutaneous Melanoma Patient Immunized With the CSF-470 Vaccine: A Case Report.
Front Immunol
; 9: 955, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29774030
5.
High neutrophil to lymphocyte ratio and decreased CD69+NK cells represent a phenotype of high risk in early-stage breast cancer patients.
Onco Targets Ther
; 11: 2901-2910, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29844687
6.
Phase II Study of Adjuvant Immunotherapy with the CSF-470 Vaccine Plus Bacillus Calmette-Guerin Plus Recombinant Human Granulocyte Macrophage-Colony Stimulating Factor vs Medium-Dose Interferon Alpha 2B in Stages IIB, IIC, and III Cutaneous Melanoma Patients: A Single Institution, Randomized Study.
Front Immunol
; 8: 625, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28620382
7.
Phenotypic and Functional Dysregulated Blood NK Cells in Colorectal Cancer Patients Can Be Activated by Cetuximab Plus IL-2 or IL-15.
Front Immunol
; 7: 413, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27777574
8.
Natural killer cells as helper cells in dendritic cell cancer vaccines.
Front Immunol
; 6: 13, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25674087
9.
Cytogenetic characterization of the murine bladder cancer model MB49 and the derived invasive line MB49-I.
Cancer Genet
; 205(4): 168-76, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22559978